Skip to main content
logo
ANI Pharmaceuticals, Inc. (ANIP)
NASDAQ: ANIP · Real-Time Price · USD
85.72
+1.09 (1.29%)
May 6, 2026, 1:55 PM EDT - Market open

ANI Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Cap
1,9501,7751,1671,129704776
Market Cap Growth
31.71%52.16%3.40%60.35%-9.25%116.16%
Enterprise Value
2,2672,0981,6651,218966.94987.41
Last Close Price
85.7278.9455.2855.1440.2346.08
PE Ratio
25.7923.78-53.1564.87-13.19-13.55
Forward PE
9.4510.0310.7214.0414.7912.86
PEG Ratio
-1.381.381.381.111.02
PS Ratio
2.192.011.902.322.223.59
PB Ratio
3.283.282.892.612.242.32
P/TBV Ratio
3.263.102.652.322.091.73
P/FCF Ratio
11.28-24.4210.25-17.561013.74
P/OCF Ratio
10.44-18.239.49-22.56233.45
EV/Sales Ratio
2.572.372.712.503.064.57
EV/EBITDA Ratio
12.9718.8824.3711.4139.68132.38
EV/EBIT Ratio
27.2118.882850.4025.93-27.41-24.81
EV/FCF Ratio
13.23-34.8411.06-24.131290.74
Debt / Equity Ratio
1.141.141.460.620.850.80
Debt / EBITDA Ratio
5.555.559.142.6811.7638.52
Debt / FCF Ratio
--13.062.60-7.15375.62
Net Debt / Equity Ratio
0.600.601.170.150.760.56
Net Debt / EBITDA Ratio
2.902.906.920.619.7825.08
Net Debt / FCF Ratio
--9.900.59-5.95244.51
Asset Turnover
0.650.650.560.580.410.35
Inventory Turnover
2.442.442.021.681.481.41
Quick Ratio
2.072.071.932.632.152.61
Current Ratio
2.712.712.723.573.463.68
Return on Equity (ROE)
16.16%16.16%-4.18%4.72%-13.74%-15.37%
Return on Assets (ROA)
6.67%6.67%0.04%5.33%-3.52%-4.91%
Return on Invested Capital (ROIC)
9.42%9.42%0.06%7.19%-4.26%-5.82%
Return on Capital Employed (ROCE)
9.86%9.86%0.06%6.62%-5.25%-7.46%
Earnings Yield
3.63%4.21%-1.88%1.54%-7.58%-7.38%
FCF Yield
8.86%0.00%4.09%9.76%-5.69%0.10%
Buyback Yield / Dilution
-9.89%-9.89%-6.18%-11.89%-29.77%-4.73%
Total Shareholder Return
-9.89%-9.89%-6.18%-11.89%-29.77%-4.73%
Updated Feb 27, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q